
Oxycodone addiction often starts with a legitimate prescription that becomes harder to manage, and tapering alone can be more difficult than expected. But rehab isn’t the only path forward. Medication for Opioid Use Disorder (MOUD) is a clinically proven approach to oxycodone addiction treatment that you can access from home through Ophelia. Get private, confidential care from licensed clinicians without public waiting rooms or time away from your daily life.
Explore treatmentCHECK YOUR COVERAGE



An Ophelia clinician reviews your medical history, current oxycodone use history, prescribed or otherwise, plus current medications and treatment goals. These factors help determine whether a tailored OUD treatment plan and buprenorphine medication are appropriate.
Most people using short-acting oxycodone, like Percocet® or Roxicodone®, wait 12–24 hours or until moderate withdrawal begins before starting buprenorphine. Your care team will guide the timing and may prescribe comfort medications.
Ophelia clinicians primarily treat OUD using buprenorphine/ naloxone (Suboxone®). Buprenorphine helps reduce cravings and withdrawal symptoms without producing the high that can lead to continued opioid misuse. Zubsolv® and generics may be prescribed when indicated.
Oxycodone and OxyContin® addiction treatment includes regular video visits for progress and medication management, with at-home urinalysis as needed. Contact our care coordinators during daily support hours for guidance between appointments.






Medication-assisted treatment takes a different approach than detox and rehab. The right option depends on factors like OUD severity and the level of care you need.
Ophelia currently operates in 16 states as we work to expand coverage nationwide. If oxycodone addiction treatment isn’t available where you live, our team can help you understand your options.
Every Ophelia patient is matched with a three-person care team: your prescribing clinician manages your treatment plan and prescription, while your nurse and care coordinator handle scheduling and medication issues. This team provides ongoing, nonjudgmental support.

Straightforward answers on visits, withdrawal support, switching providers and getting started.
OxyContin is the extended-release form of oxycodone, so medication-assisted treatment (MAT) applies to both substances. However, treatment plans are individualized and may look different.
Yes. The FDA warns that addiction can occur when oxycodone is taken at recommended doses. If you’re struggling to manage oxycodone use, contact Ophelia to schedule a private telehealth evaluation.
FDA-approved OUD medications include buprenorphine, methadone, and naltrexone. Ophelia primarily prescribes buprenorphine/naloxone (Suboxone). Your clinician will determine if medication is right for you based on your health history and needs.
Most people need to wait until mild withdrawal before starting buprenorphine. For short-acting opioids like oxycodone, this typically occurs 12-24 hours after last use. Your clinician will provide instructions to help time your transition.
Usually, no. Most patients start buprenorphine at home under clinician guidance. In rare cases, your clinician may recommend detox or a different level of care based on acute medical or psychiatric needs.
Ophelia provides online oxycodone and OxyContin addiction treatment to patients in select states. If medication is appropriate, your clinician will send a prescription to your local pharmacy.
Many commercial insurance plans cover oxycodone and OxyContin addiction treatment, along with Medicare and Medicaid. Coverage and expenses can vary, but our enrollment team helps new patients understand their coverage and costs.
